Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$722K Sell
2,136
-52
-2% -$18.5K 0.05% 214
2025
Q4
$716K Sell
2,188
-24
-1% -$7.61K 0.05% 215
2025
Q3
$624K Buy
2,212
+1
+0% +$290 0.04% 237
2025
Q2
$617K Buy
2,211
+16
+0.7% +$4.53K 0.04% 228
2025
Q1
$684K Sell
2,195
-52
-2% -$15.4K 0.06% 184
2024
Q4
$586K Sell
2,247
-163
-7% -$48.4K 0.05% 197
2024
Q3
$777K Sell
2,410
-1,882
-44% -$616K 0.06% 162
2024
Q2
$1.43M Buy
4,292
+39
+0.9% +$11.5K 0.13% 120
2024
Q1
$1.21M Buy
4,253
+1,012
+31% +$296K 0.11% 130
2023
Q4
$934K Buy
+3,241
New +$883K 0.1% 133
2022
Q4
$529K Buy
2,016
+261
+15% +$70K 0.06% 187
2022
Q3
$396K Buy
+1,755
New +$425K 0.05% 201

Other funds holding AMGN

Icon Wealth Advisors's AMGN Position: Q1 2026 in Review

Icon Wealth Advisors reduced its Amgen (AMGN) stake by 2.4% in Q1 2026, selling an estimated $18.5K and leaving 2,136 shares worth $722K. The position accounts for 0.05% of the portfolio, ranked #214.

Icon Wealth Advisors first reported a position in AMGN in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.43M in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Icon Wealth Advisors held 2,136 shares of Amgen worth $722K as of Q1 2026.
  • Icon Wealth Advisors sold 52 Amgen shares in Q1 2026, an estimated $18.5K.
  • Amgen made up 0.05% of Icon Wealth Advisors's portfolio in Q1 2026, its #214 holding.
  • Icon Wealth Advisors first reported a position in Amgen in Q3 2022 and has held it in 12 quarters since.
  • Icon Wealth Advisors's Amgen position peaked at $1.43M in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.